Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT05753787

Eye Surface Properties After Using Dexamethasone Drops With and Without Preservatives in Patients After Cataract Surgery

Conditions: Cataract, Surgical Injury, Healing Wound

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 40
Sponsor: Spektrum Center of Clinical Ophthalmology

Location: Poland

Summary

The goal of this interventional, real world data study is to evaluate the impact of preservatives on the post-cataract ocular surface.The main question is to learn about an effect of preservatives on the eye surface. The study aims to answer some important questions:if the usage of preservatives has an impact on the eye surface healing process after cataract surgeryif patient comfort and quality of life improve more or more rapidly with preservatives-free eye drops.Participants will be asked to undergo standard procedure of peri-cataract surgery care and in addition to survey about the ocular surface state.Researchers will compare group that takes preservatives-free dexamethasone 0.1% with standard dexamethasone 0.01% solution to see if post-surgery eye surface healing properties differ from both groups.

Eligibility Criteria

Inclusion Criteria:cataract surgery required defined previously by the eye-care specialistgood and clear visibility of the anterior chamber in the pre-surgery status (enables investigators to assess the anterior chamber cell intensity)consent to the study protocolExclusion Criteria:diagnosed glaucomadiagnosed previous allergydiagnosed diabetic retinopathy or maculopathypreviously diagnosed dry eye disease that requires treatment with multiple artificial tearspermanent usage of the eye drops other than artificial tearsnon-compliance to the study protocol

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05753787). StuddyBuddy aggregates publicly available trial information.